Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jun;75(6):1523-1531.
doi: 10.1161/HYPERTENSIONAHA.120.14701. Epub 2020 Apr 27.

T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia: An Observational Cohort Study

Alison E P Ho  1 , Jana Hutter  2   3 , Laurence H Jackson  2   3 , Paul T Seed  1 , Laura Mccabe  2 , Mudher Al-Adnani  4 , Andreas Marnerides  4 , Simi George  4 , Lisa Story  1 , Joseph V Hajnal  2   3 , Mary A Rutherford #  2 , Lucy C Chappell #  1
Affiliations
Observational Study

T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia: An Observational Cohort Study

Alison E P Ho et al. Hypertension. 2020 Jun.

Abstract

Placental dysfunction underlies the cause of pregnancies complicated by preeclampsia. The use of placental magnetic resonance imaging to provide an insight into the pathophysiology of preeclampsia and thus assess its potential use to inform prognosis and clinical management was explored. In this prospective observational cohort study, 14 women with preterm preeclampsia and 48 gestation-matched controls using 3-Tesla magnetic resonance imaging at median of 31.6 weeks (interquartile range [IQR], 28.6-34.6) and 32.2 weeks (IQR, 28.6-33.8), respectively, were imaged. The acquired data included T2-weighted images and T2* maps of the placenta, the latter an indicative measure of placental oxygenation. Placentae in women with preeclampsia demonstrated advanced lobulation, varied lobule sizes, high granularity, and substantial areas of low-signal intensity on T2-weighted imaging, with reduced entire placental mean T2* values for gestational age (2 sample t test, t=7.49) correlating with a reduction in maternal PlGF (placental growth factor) concentrations (Spearman rank correlation coefficient 0.76) and increased lacunarity values (t=3.26). Median mean T2* reduced from 67 ms (IQR, 54-73) at 26.0 to 29.8 weeks' gestation to 38 ms (IQR, 28-40) at 34.0 to 37.9 weeks' gestation in the control group. In women with preeclampsia, median T2* was 23 ms (IQR, 20-23) at 26.0 to 29.8 weeks' gestation and remained low (22 ms [IQR, 20-26] at 34.0-37.8 weeks' gestation). Histological features of maternal vascular malperfusion were only found in placentae from women with preeclampsia. Placental volume did not differ between the control group and women with preeclampsia. Placental magnetic resonance imaging allows both objective quantification of placental function in vivo and elucidation of the complex mechanisms underlying preeclampsia development.

Keywords: magnetic resonance imaging; placenta; preeclampsia; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
T2-weighted imaging and T2* maps. A, Example T2-weighted imaging and T2* maps in coronal and sagittal planes across gestation. B, Features of T2-weighted imaging in women with preeclampsia.
Figure 2.
Figure 2.
Scatterplot of placental mean T2* against gestational age at imaging, lines representing 10th, 50th, and 90th centiles. Actual placental mean T2* values given in Table S2 in the Data Supplement.
Figure 3.
Figure 3.
MRI derived measures and placental growth factor concentrations in both groups (control and preeclampsia). A, Scatterplot of lacunarity measure (derived from T2* mapping) against gestational age at imaging. Actual placental lacunarity values given in Table S2 in the Data Supplement. B, Scatterplot of PlGF (placental growth factor; sample taken within 2 wk of magnetic resonance imaging) against placental mean T2* (derived from T2* mapping).
See this image and copyright information in PMC

Comment in

References

    1. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391–403. doi: 10.1016/j.bpobgyn.2011.01.006. - PubMed
    1. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, et al. Saving Mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(suppl 1):1–203. doi: 10.1111/j.1471-0528.2010.02847.x. - PubMed
    1. Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015;5:a023473. doi: 10.1101/cshperspect.a023473. - PMC - PubMed
    1. Kingdom JC, Audette MC, Hobson SR, Windrim RC, Morgen E. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2s):S803–S817. doi: 10.1016/j.ajog.2017.11.575. - PubMed
    1. Cameron IL, Ord VA, Fullerton GD. Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging. 1984;2:97–106. doi: 10.1016/0730-725x(84)90063-8. - PubMed

Publication types

MeSH terms

Substances